JP2022515140A5 - - Google Patents
Info
- Publication number
- JP2022515140A5 JP2022515140A5 JP2021535612A JP2021535612A JP2022515140A5 JP 2022515140 A5 JP2022515140 A5 JP 2022515140A5 JP 2021535612 A JP2021535612 A JP 2021535612A JP 2021535612 A JP2021535612 A JP 2021535612A JP 2022515140 A5 JP2022515140 A5 JP 2022515140A5
- Authority
- JP
- Japan
- Prior art keywords
- modified
- modified oligonucleotide
- compound according
- nucleosides
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024163353A JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Pmp22の発現を低減するための化合物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862783997P | 2018-12-21 | 2018-12-21 | |
| US62/783,997 | 2018-12-21 | ||
| PCT/US2019/068040 WO2020132558A1 (en) | 2018-12-21 | 2019-12-20 | Compounds and methods for reducing pmp22 expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163353A Division JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Pmp22の発現を低減するための化合物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515140A JP2022515140A (ja) | 2022-02-17 |
| JP2022515140A5 true JP2022515140A5 (cg-RX-API-DMAC7.html) | 2022-12-14 |
| JP7561129B2 JP7561129B2 (ja) | 2024-10-03 |
Family
ID=71101859
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535612A Active JP7561129B2 (ja) | 2018-12-21 | 2019-12-20 | Pmp22の発現を低減するための化合物及び方法 |
| JP2024163353A Pending JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Pmp22の発現を低減するための化合物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163353A Pending JP2025000717A (ja) | 2018-12-21 | 2024-09-20 | Pmp22の発現を低減するための化合物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220112503A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3897837A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7561129B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020132558A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY203356A (en) | 2018-01-12 | 2024-06-25 | Bristol Myers Squibb Co | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
| WO2019140236A1 (en) | 2018-01-12 | 2019-07-18 | Bristol-Myers Squibb Company | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
| WO2021258011A1 (en) * | 2020-06-19 | 2021-12-23 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating pmp22 |
| WO2022119826A1 (en) * | 2020-12-01 | 2022-06-09 | Research Institute At Nationwide Children's Hospital | Products and methods for inhibition of expression of peripheral myelin protein-22 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198983A1 (en) * | 2002-02-01 | 2003-10-23 | Affymetrix, Inc. | Methods of genetic analysis of human genes |
| WO2005005989A1 (en) * | 2003-07-11 | 2005-01-20 | F. Hoffmann-La Roche Ag | A method for predicting the metastatic potential of breast cancer |
| US9005935B2 (en) * | 2011-05-23 | 2015-04-14 | Agilent Technologies, Inc. | Methods and compositions for DNA fragmentation and tagging by transposases |
| WO2012177639A2 (en) * | 2011-06-22 | 2012-12-27 | Alnylam Pharmaceuticals, Inc. | Bioprocessing and bioproduction using avian cell lines |
| WO2016161378A1 (en) * | 2015-04-03 | 2016-10-06 | University Of Massachusetts | Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders |
| ES2903394T3 (es) * | 2015-12-14 | 2022-04-01 | Cold Spring Harbor Laboratory | Composiciones para el tratamiento de la retinitis pigmentosa 13 |
| AU2017229778A1 (en) * | 2016-03-09 | 2018-08-16 | Ionis Pharmaceuticals, Inc. | Methods and compositions for inhibiting PMP22 expression |
| CN106755390B (zh) * | 2016-12-15 | 2020-12-04 | 上海东方杰玛基因生物科技有限公司 | 一种用于皮肤抗衰老能力基因检测的引物组合物及检测方法 |
| KR101889072B1 (ko) * | 2017-09-15 | 2018-08-16 | 한국생명공학연구원 | 디지털 PCR을 이용한 유전성 강직성 대마비(Hereditary spastic paraplegia, HSP) 관련 유전자 SPG4의 거대결손 검증법 |
-
2019
- 2019-12-20 EP EP19899128.3A patent/EP3897837A4/en active Pending
- 2019-12-20 JP JP2021535612A patent/JP7561129B2/ja active Active
- 2019-12-20 US US17/416,392 patent/US20220112503A1/en active Pending
- 2019-12-20 WO PCT/US2019/068040 patent/WO2020132558A1/en not_active Ceased
-
2024
- 2024-09-20 JP JP2024163353A patent/JP2025000717A/ja active Pending